Dr. Jean Bourbeau on a promising new treatment to prevent severe COVID-19

Canada is leading the way with a new treatment for severe COVID-19 that could change the course of the pandemic for developing countries. PULM-001 is an innovative treatment to reduce and possibly prevent the development of severe pulmonary inflammation caused by COVID. Dr. Jean Bourbeau from the Research Institute of the MUHC will lead the phase III trial in partnership with Canadian start-up Pulmonem. The study will be conducted remotely, with patients in Ontario and Quebec, and recruitment launches June 28th. He joined Elias Makos on CJAD 800AM to discuss the Phase III clinical trial.